1. General Pathology - cell injury, inflammation, wound healing
2. Neoplasia - tumor biology, grading/staging, carcinogenesis
3. Hematology - anemias, leukemias, lymphomas, bleeding disorders
4. Cardiovascular Pathology - atherosclerosis, MI, cardiomyopathies
5. Any other specific topic (e.g., Renal, GI, Respiratory, Breast, etc.)

Topic Breakdown (Robbins - Neoplasia)

1. Nomenclature - benign vs malignant tumor naming (-oma, carcinoma, sarcoma, exceptions)
2. Characteristics of Benign vs Malignant Neoplasms - differentiation, anaplasia, local invasion, metastasis (routes, patterns)
3. Epidemiology - incidence, environmental factors, age, predisposing conditions (precancerous states)
4. Cancer Genes & Genetic Lesions - driver/passenger mutations, point mutations, translocations, amplifications, epigenetics, miRNA
5. Carcinogenesis - Multistep Process - initiation, promotion, progression
6. Hallmarks of Cancer (the high-yield core):
   • Self-sufficiency in growth signals (oncogenes, growth factors/receptors, RAS-RAF-MAPK, PI3K-AKT)
   • Insensitivity to growth inhibition (tumor suppressors: RB, TP53)
   • Altered cellular metabolism (Warburg effect)
   • Evasion of apoptosis
   • Limitless replicative potential (telomerase)
   • Sustained angiogenesis
   • Invasion and metastasis (EMT, cascade)
   • Evasion of immune surveillance
7. Chemical, Radiation & Microbial Carcinogenesis - carcinogens (direct/indirect), oncogenic viruses (HPV, EBV, HBV), H. pylori
8. Tumor Immunology - tumor antigens, immune evasion mechanisms
9. Clinical Features of Tumors - local/hormonal effects, cancer cachexia, paraneoplastic syndromes
10. Grading and Staging - histologic grading vs TNM/AJCC staging (very NEET PG relevant)
11. Lab Diagnosis of Cancer - histology, cytology (Pap smear), immunohistochemistry, molecular diagnostics, tumor markers (PSA, CEA, AFP, CA-125, etc.)

Brief Overview

1. General Pathology - cell injury, inflammation, wound healing
2. Neoplasia - tumor biology, grading/staging, carcinogenesis
3. Hematology - anemias, leukemias, lymphomas, bleeding disorders
4. Cardiovascular Pathology - atherosclerosis, MI, cardiomyopathies
5. Any other specific topic (e.g., Renal, GI, Respiratory, Breast, etc.)

Topic Breakdown (Robbins - Neoplasia)

1. Nomenclature - benign vs malignant tumor naming (-oma, carcinoma, sarcoma, exceptions)
2. Characteristics of Benign vs Malignant Neoplasms - differentiation, anaplasia, local invasion, metastasis (routes, patterns)
3. Epidemiology - incidence, environmental factors, age, predisposing conditions (precancerous states)
4. Cancer Genes & Genetic Lesions - driver/passenger mutations, point mutations, translocations, amplifications, epigenetics, miRNA
5. Carcinogenesis - Multistep Process - initiation, promotion, progression
6. Hallmarks of Cancer (the high-yield core):
   • Self-sufficiency in growth signals (oncogenes, growth factors/receptors, RAS-RAF-MAPK, PI3K-AKT)
   • Insensitivity to growth inhibition (tumor suppressors: RB, TP53)
   • Altered cellular metabolism (Warburg effect)
   • Evasion of apoptosis
   • Limitless replicative potential (telomerase)
   • Sustained angiogenesis
   • Invasion and metastasis (EMT, cascade)
   • Evasion of immune surveillance
7. Chemical, Radiation & Microbial Carcinogenesis - carcinogens (direct/indirect), oncogenic viruses (HPV, EBV, HBV), H. pylori
8. Tumor Immunology - tumor antigens, immune evasion mechanisms
9. Clinical Features of Tumors - local/hormonal effects, cancer cachexia, paraneoplastic syndromes
10. Grading and Staging - histologic grading vs TNM/AJCC staging (very NEET PG relevant)
11. Lab Diagnosis of Cancer - histology, cytology (Pap smear), immunohistochemistry, molecular diagnostics, tumor markers (PSA, CEA, AFP, CA-125, etc.)

Brief Overview

NEOPLASIA - Part 1: Nomenclature & Benign vs Malignant Characteristics

1. NOMENCLATURE OF TUMORS

A. Benign Tumors

• General suffix: "-oma" added to cell/tissue of origin
• Mesenchymal origin:
  • Fibroma (fibrous tissue), Lipoma (fat), Chondroma (cartilage), Osteoma (bone), Leiomyoma (smooth muscle), Rhabdomyoma (skeletal muscle), Hemangioma (blood vessels)
• Epithelial origin (more complex, based on pattern):
  • Adenoma - glandular pattern (e.g., thyroid adenoma) or from glands (regardless of pattern)
  • Papilloma - finger-like/frond projections (squamous papilloma)
  • Polyp - projects above a mucosal surface (e.g., colonic polyp) - can be benign or malignant
  • Cystadenoma - cystic mass (e.g., ovarian serous cystadenoma)

B. Malignant Tumors

• Mesenchymal origin -> "Sarcoma"
  • Fibrosarcoma, Liposarcoma, Chondrosarcoma, Osteosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Angiosarcoma
• Epithelial origin -> "Carcinoma"
  • Adenocarcinoma - glandular growth pattern
  • Squamous cell carcinoma - squamous differentiation
  • Can specify organ: renal cell carcinoma, hepatocellular carcinoma

C. Important Exceptions (HIGH-YIELD, frequently asked as "-oma but malignant")

D. Mixed Tumors (more than one cell type from single germ layer)

• Pleomorphic adenoma of salivary gland (epithelial + myoepithelial + mesenchyme-like stroma)
• Fibroadenoma of breast (fibrous + glandular)

E. Teratoma

• Arises from totipotent germ cells - contains tissue from all 3 germ layers (ectoderm, mesoderm, endoderm)
• Site: ovary, testis, sacrococcygeal, mediastinum
• Mature teratoma - usually benign (esp. ovary)
• Immature teratoma - malignant potential

Clinical Correlation: In an ovarian mature cystic teratoma ("dermoid cyst"), look for hair, sebaceous material, teeth (Rokitansky protuberance) on imaging - classic NEET PG image-based question.

2. CHARACTERISTICS OF BENIGN VS MALIGNANT NEOPLASMS

A. Differentiation and Anaplasia

Clinical/Exam Correlation:

• Anaplastic thyroid carcinoma, anaplastic large cell lymphoma - aggressive tumors named for this feature.
• Dysplasia is a pre-neoplastic change (disordered growth, seen in cervix - CIN grading, Barrett esophagus) - reversible, distinguish from anaplasia (irreversible, in cancer cells) - a favorite MCQ distractor.

B. Rate of Growth

• Benign: usually slow (may be influenced by hormones - e.g., leiomyoma grows in pregnancy, shrinks after menopause)
• Malignant: usually rapid, correlates with grade; growth rate correlates with mitotic index and level of differentiation
• Doubling time and growth fraction determine chemotherapy response (rapidly dividing tumors like lymphomas respond better to cell-cycle-specific drugs)

C. Local Invasion

Clinical Correlation: Surgical enucleation works for benign, encapsulated tumors (e.g., fibroadenoma); malignant tumors need wide margins because of infiltrative microscopic extensions beyond the visible/palpable mass.

D. Metastasis

1. Direct seeding of body cavities/surfaces - e.g., ovarian cancer seeding peritoneal cavity; called transcoelomic spread
2. Lymphatic spread - typical of carcinomas; follows natural lymphatic drainage
   • Breast cancer -> axillary nodes (outer quadrant) or internal mammary nodes (inner quadrant)
   • Lung cancer -> hilar/tracheobronchial nodes
   • Sentinel lymph node biopsy concept used clinically (breast, melanoma)
3. Hematogenous spread - typical of sarcomas, also carcinomas (renal cell, hepatocellular, follicular thyroid, choriocarcinoma)
   • Veins invaded more often than arteries (lower resistance)
   • Liver and lungs most frequently involved because of venous drainage patterns (portal system -> liver; systemic venous -> lung, "first-pass" capillary bed)
   • Follows venous flow: GI cancers -> liver (portal drainage); tumors in the vena cava drainage -> lungs first

Clinical Correlation (very high-yield):

• Renal cell carcinoma invades renal vein -> IVC -> can extend to right atrium (classic imaging/surgical case)
• Follicular thyroid carcinoma spreads hematogenously (unlike papillary which spreads via lymphatics) -> bone/lung metastases
• Prostate cancer -> osteoblastic (sclerotic) bone metastases (classic! vs most other carcinomas which are osteolytic)
• Breast, lung, thyroid, kidney carcinomas -> often osteolytic bone metastases
• Common sites of metastasis (liver and lung most common overall) - but interestingly, spleen, heart, and skeletal muscle are relatively resistant to metastasis despite good blood flow (classic exam trick question)
• "Some organs are surprisingly resistant to secondary tumors" - asked as reverse question in NEET PG

Quick Revision Table: Benign vs Malignant

Diagram concept (describe if you want me to generate an image)

• Left panel (benign): encapsulated mass with regular cells, uniform nuclei, pushing border
• Right panel (malignant): irregular infiltrative margins breaching capsule/basement membrane, pleomorphic cells with hyperchromatic nuclei, abnormal mitoses, lymphovascular invasion, and a distant metastatic nodule in liver/lung

1. Carcinogenesis + Hallmarks of Cancer (oncogenes, TSGs, RB/p53 pathways)
2. Grading & Staging + Tumor Markers
3. Carcinogens (chemical/radiation/viral) + Paraneoplastic syndromes

WBC Disorders - Topic Map for MBBS Pathology

1. Normal leukocyte count and differential count
2. Leukocytosis and leukopenia
   • Neutrophilia and neutropenia
   • Lymphocytosis and lymphopenia
   • Eosinophilia
   • Basophilia
   • Monocytosis
3. Reactive disorders
   • Leukemoid reaction
   • Infectious mononucleosis
4. Acute leukemias
   • Acute myeloid leukemia (AML)
   • Acute lymphoblastic leukemia (ALL)
5. Chronic myeloproliferative neoplasms
   • Chronic myeloid leukemia (CML)
   • Polycythemia vera, essential thrombocythemia, primary myelofibrosis
6. Myelodysplastic syndromes
7. Lymphoid neoplasms
   • Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
   • Hodgkin lymphoma
   • Non-Hodgkin lymphomas
   • Plasma-cell neoplasms, including multiple myeloma
8. Approach to a patient with abnormal WBC count
   • CBC and peripheral smear
   • Bone marrow examination
   • Cytochemistry
   • Flow cytometry
   • Cytogenetics and molecular studies

High-yield overview

• Leukocytosis means total WBC count is raised. It may be reactive, such as bacterial infection causing neutrophilia, or malignant, such as leukemia.
• Leukopenia means reduced WBC count, most clinically important when due to neutropenia, because severe infection risk rises sharply.
• Leukemoid reaction is a marked reactive neutrophilia that can mimic CML. Classic differentiation: leukocyte alkaline phosphatase score is high in leukemoid reaction and low in CML; CML has BCR-ABL1 fusion.
• Acute leukemia presents with marrow failure: anemia, infections due to neutropenia, and bleeding due to thrombocytopenia. Blasts are the key cells.
• Chronic leukemia tends to present more gradually with marked leukocytosis and splenomegaly.
• In exam questions, the peripheral smear, age, organomegaly, lymph-node status, cytochemical stains, immunophenotype, and characteristic translocations often provide the diagnosis.

1. Leukocytosis, leukopenia, leukemoid reaction
2. AML and ALL
3. CML and other myeloproliferative neoplasms
4. CLL, Hodgkin lymphoma, and non-Hodgkin lymphoma
5. Complete WBC disorders series, one topic at a time

Neutropenia, Leukocytosis, and Leukemoid Reaction

MBBS Pathology Notes for NEET PG / INICET

1. NEUTROPENIA

Definition

• Normal ANC: approximately 1,500 to 7,500/µL
• Neutropenia: ANC <1,500/µL
• Mild: 1,000 to 1,500/µL
• Moderate: 500 to 1,000/µL
• Severe: <500/µL
• Profound: <200/µL

Exam point: Do not diagnose neutropenia from the neutrophil percentage alone. Calculate the ANC.

Example

• Total WBC = 2,000/µL
• Neutrophils = 20%, bands = 5%

Etiopathogenesis: Mechanisms of Neutropenia

1. Decreased marrow production
2. Increased peripheral destruction or consumption
3. Abnormal distribution/sequestration

A. Decreased Bone Marrow Production

Causes

1. Drugs and toxins
   • Cytotoxic chemotherapy
   • Chloramphenicol
   • Antithyroid drugs: carbimazole, methimazole, propylthiouracil
   • Clozapine
   • Sulfonamides
   • Some anticonvulsants
   • Alcohol
   • Radiation
2. Bone marrow failure/infiltration
   • Aplastic anemia
   • Acute leukemia
   • Myelodysplastic syndrome
   • Myelofibrosis
   • Metastatic tumor infiltration
3. Nutritional deficiency
   • Vitamin B12 deficiency
   • Folate deficiency
   • Copper deficiency
4. Infections suppressing marrow
   • HIV
   • Hepatitis viruses
   • EBV
   • Parvovirus B19
   • Severe sepsis

Clinical correlation: Chemotherapy commonly causes neutrophil nadir roughly 5 to 10 days after treatment. A febrile patient during this period is treated as having a medical emergency until proven otherwise.

B. Increased Peripheral Destruction or Consumption

1. Autoimmune neutropenia
   • Systemic lupus erythematosus
   • Rheumatoid arthritis
   • Autoimmune neutropenia of infancy
   • Drug-induced immune neutropenia
2. Severe infection/sepsis
   • Neutrophils are consumed rapidly at sites of infection.
   • Severe bacterial sepsis may paradoxically cause neutropenia rather than neutrophilia.
3. Hypersplenism
   • Splenic sequestration and increased removal of cells
   • Common in portal hypertension, malaria, kala-azar, and some hematological malignancies

C. Abnormal Distribution

• Margination or pooling of neutrophils may produce transient low circulating neutrophil count.
• Seen in overwhelming infection, endotoxemia, and occasionally after hemodialysis.

Important Specific Disorders

1. Congenital Severe Neutropenia

• Also called Kostmann syndrome in a classic severe form.
• Presents in infancy with recurrent severe bacterial infections.
• Causes: mutations involving neutrophil maturation pathways, commonly ELANE in many inherited forms.
• Bone marrow: maturation arrest of granulopoiesis.
• May progress to myelodysplastic syndrome or AML in some forms.

2. Cyclic Neutropenia

• Usually due to ELANE mutation.
• Periodic fall in ANC, classically every 21 days.
• During neutropenic phase:
  • Fever
  • Mouth ulcers
  • Gingivitis
  • Pharyngitis
  • Skin infections

3. Benign Ethnic Neutropenia

• More accurately called Duffy-null associated neutrophil count.
• Seen more often in people of African, Middle Eastern, and some Mediterranean ancestries.
• Usually mild chronic neutropenia.
• No increased susceptibility to serious infection in otherwise healthy individuals.
• Important to avoid wrongly labelling such patients as having marrow disease.

Clinical Features

Typical findings

• Fever, often the only sign
• Recurrent oral ulcers
• Gingivitis and periodontitis
• Pharyngitis
• Skin infections
• Pneumonia
• Perianal infections
• Sepsis

Why signs may be deceptively mild

• Minimal pus formation
• Little local redness/swelling
• No leukocytosis
• Severe infection despite subtle examination findings

Very high-yield: Fever in a severely neutropenic patient = febrile neutropenia, a medical emergency.

Diagnosis

Stepwise approach

1. CBC with differential count
   • Confirm low ANC.
2. Peripheral blood smear
   • Look for blasts, dysplasia, pancytopenia, megaloblastic changes.
3. History
   • Recent chemotherapy or radiation
   • Drugs, including antithyroid drugs and clozapine
   • Infection history
   • Family history
   • Autoimmune disease
4. Look for infection
   • Blood cultures if febrile
   • Urine/sputum cultures when indicated
   • Chest imaging or targeted imaging based on symptoms
5. Bone marrow examination
   • When persistent, severe, unexplained neutropenia, pancytopenia, blasts, or suspected marrow pathology is present.
6. Additional tests as indicated
   • Vitamin B12, folate, copper
   • Viral serology
   • ANA/autoimmune workup
   • Flow cytometry/cytogenetics for suspected hematologic malignancy

Management Principles

• Treat the underlying cause.
• Stop the suspected offending drug when appropriate.
• Infection prevention measures in severe or prolonged neutropenia.
• Fever + severe neutropenia: obtain cultures promptly and start empiric broad-spectrum antipseudomonal antibiotics without delay, according to local protocol.
• G-CSF can be used after chemotherapy and in selected chronic severe neutropenias to stimulate neutrophil production.

2. LEUKOCYTOSIS

Definition

• In adults, commonly defined as WBC >11,000/µL.
• It is not a diagnosis. It is a laboratory finding that can be:
  1. Reactive: infection, inflammation, stress, drugs
  2. Clonal/neoplastic: leukemia, myeloproliferative neoplasm

Exam point: Always identify which leukocyte lineage is increased. Total WBC count alone is insufficient.

Types of Leukocytosis

A. Neutrophilic Leukocytosis / Neutrophilia

Definition

• Increased absolute neutrophil count, often approximately >7,500/µL in adults.
• Most common cause of leukocytosis.

Causes: Remember "Infection, Inflammation, Injury, Injection, Intoxication"

1. Acute bacterial infection
   • Pneumonia
   • Appendicitis
   • Pyelonephritis
   • Meningitis
2. Acute inflammation/tissue necrosis
   • Myocardial infarction
   • Burns
   • Trauma
   • Acute pancreatitis
   • Gout
3. Drugs
   • Corticosteroids
   • Adrenaline/epinephrine
   • G-CSF
   • Lithium
4. Stress demargination
   • Exercise
   • Seizure
   • Acute pain
   • Emotional stress
5. Smoking
6. Malignancy
   • CML
   • Chronic neutrophilic leukemia
   • Some solid tumors producing G-CSF or GM-CSF

Left Shift

Sequence of granulocytic maturation

Myeloblast → Promyelocyte → Myelocyte → Metamyelocyte → Band cell → Segmented neutrophil

• Mild left shift: increased band forms
• Severe infection/leukemoid reaction: metamyelocytes and myelocytes may appear
• Blasts in peripheral blood suggest acute leukemia or severe marrow stress, but need careful interpretation.

Peripheral smear features supporting reactive neutrophilia

• Left shift
• Toxic granulation
• Döhle bodies
• Cytoplasmic vacuolation

B. Lymphocytosis

Causes

• Viral infections: EBV, CMV, hepatitis, mumps, rubella
• Pertussis
• Tuberculosis and some chronic infections
• CLL and other lymphoproliferative disorders

Clinical correlation: Infectious mononucleosis has atypical/reactive lymphocytes. These are mainly activated CD8+ T cells, not malignant lymphocytes.

C. Eosinophilia

Causes: "NAPAD"

• Neoplasia: Hodgkin lymphoma, some myeloid neoplasms
• Allergy: asthma, allergic rhinitis, atopy
• Parasites: especially helminths with tissue migration
• Autoimmune/vasculitis: EGPA
• Drugs: DRESS and drug hypersensitivity

3. LEUKEMOID REACTION

Definition

• Common operational cutoff: WBC/neutrophil count >50,000/µL
• Some references use approximately 30,000 to 50,000/µL for marked leukemoid neutrophilia.
• It must be differentiated especially from CML.

Causes of Leukemoid Reaction

1. Severe infection

• Sepsis
• Clostridioides difficile colitis
• Severe pneumonia
• Tuberculosis
• Disseminated infections

2. Severe tissue injury or inflammation

• Burns
• Severe trauma
• Acute pancreatitis
• Massive hemorrhage
• Extensive tissue necrosis

3. Malignancy

• Solid tumors may release cytokines such as G-CSF or GM-CSF.
• Can cause paraneoplastic leukemoid reaction.

4. Drugs

• G-CSF
• Corticosteroids may contribute to neutrophilia, though usually not by themselves to extreme levels.

Peripheral Smear in Leukemoid Reaction

• Marked neutrophilia
• Left shift: bands, metamyelocytes, and myelocytes may be present
• Usually predominantly mature neutrophils
• Toxic granulation
• Döhle bodies
• Cytoplasmic vacuolation
• Blasts are absent or extremely rare

Leukemoid Reaction vs CML

Must-know NEET PG/INICET Table

Molecular hallmark of CML

t(9;22)(q34;q11.2)
     ↓
Philadelphia chromosome
     ↓
BCR::ABL1 fusion gene
     ↓
Constitutively active tyrosine kinase

Most decisive modern test: Detection of BCR::ABL1 by PCR/FISH supports CML.
LAP score is historically important and remains a favorite exam question, but molecular testing is definitive.

Easy Flowchart for an Increased WBC Count

Raised WBC count
       ↓
Identify predominant cell type on CBC + peripheral smear
       ↓
Neutrophilia?
       ↓
Look for infection, inflammation, steroids, stress, trauma
       ↓
Toxic granules/Döhle bodies + high LAP
       → Reactive neutrophilia / leukemoid reaction
       ↓
Persistent marked leukocytosis + basophilia + splenomegaly
       ↓
Test for BCR::ABL1
       → CML if positive

One-Minute Revision

• Neutropenia = ANC <1,500/µL.
• Severe neutropenia = ANC <500/µL.
• Calculate ANC: WBC × (% neutrophils + bands)/100.
• Fever with severe neutropenia is an emergency.
• Leukocytosis = WBC >11,000/µL in adults.
• Neutrophilia commonly occurs in bacterial infection, inflammation, trauma, corticosteroid use, stress, and CML.
• Left shift = increased immature granulocytes in blood.
• Reactive neutrophilia shows toxic granulation, Döhle bodies, and vacuoles.
• Leukemoid reaction = marked reactive neutrophilic leukocytosis, often >50,000/µL.
• Leukemoid reaction: high LAP, toxic granules, no BCR::ABL1.
• CML: low LAP, basophilia, splenomegaly, BCR::ABL1 positive.

Clinical caution